Lantheus Holdings (LNTH) Depreciation & Amortization (CF) (2014 - 2016)

Lantheus Holdings' (LNTH) quarterly Depreciation & Amortization (CF) came in at -$5.4 million in Q4 2016, down 279.82% year-on-year from $3.0 million in Q1 2016, and down 240.55% on a QoQ basis from $3.8 million in Q3 2016.

Lantheus Holdings (LNTH) Depreciation & Amortization (CF) (2014 - 2016) Analysis & Trends

Lantheus Holdings (LNTH) has 3 years of Depreciation & Amortization (CF) data on file, last reported at -$5.4 million in Q4 2016.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 279.82% year-over-year to -$5.4 million in Q4 2016; TTM through Sep 2017 was -$5.4 million, a 133.33% decrease from a year earlier, with the FY2016 full-year figure at $800000.0, down 95.93% from the prior year.
  • Depreciation & Amortization (CF) for Q4 2016 stood at -$5.4 million, down from $3.8 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for LNTH reached as high as $8.1 million in Q1 2015 and fell as low as -$5.4 million in Q4 2016.
  • Historically, Depreciation & Amortization (CF) has averaged $3.5 million across 3 years, with a median of $4.2 million in 2014.
  • Across the five-year window, Depreciation & Amortization (CF) surged 112.05% in 2015 and plunged 279.82% in 2016, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $4.2 million in 2014, then declined by 28.77% to $3.0 million in 2015, then plunged by 279.82% to -$5.4 million in 2016.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were -$5.4 million in Q4 2016, $3.8 million in Q3 2016, and $4.8 million in Q2 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2016 -5.40 Mn
Dec 31, 2016 -5.40 Mn
Sep 30, 2016 3.84 Mn
Sep 30, 2016 3.84 Mn
Jun 30, 2016 4.77 Mn
Jun 30, 2016 4.77 Mn
Mar 31, 2016 4.59 Mn
Mar 31, 2016 4.59 Mn
Dec 31, 2015 3.00 Mn
Dec 31, 2015 3.00 Mn
Sep 30, 2015 4.08 Mn
Sep 30, 2015 4.08 Mn
Jun 30, 2015 4.45 Mn
Jun 30, 2015 4.45 Mn
Mar 31, 2015 8.12 Mn
Mar 31, 2015 8.12 Mn
Dec 31, 2014 4.22 Mn
Dec 31, 2014 4.22 Mn
Sep 30, 2014 4.93 Mn
Sep 30, 2014 4.93 Mn